Duopharma Biotech Bhd
KLSE:DPHARMA
Duopharma Biotech Bhd
Cash from Operating Activities
Duopharma Biotech Bhd
Cash from Operating Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Duopharma Biotech Bhd
KLSE:DPHARMA
|
Cash from Operating Activities
myr93.6m
|
CAGR 3-Years
136%
|
CAGR 5-Years
7%
|
CAGR 10-Years
13%
|
|
|
P
|
PeterLabs Holdings Bhd
KLSE:PLABS
|
Cash from Operating Activities
myr9.5m
|
CAGR 3-Years
18%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
14%
|
|
|
A
|
Apex Healthcare Bhd
KLSE:AHEALTH
|
Cash from Operating Activities
myr69m
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
7%
|
|
|
R
|
Rhone Ma Holdings Bhd
KLSE:RHONEMA
|
Cash from Operating Activities
myr18.8m
|
CAGR 3-Years
19%
|
CAGR 5-Years
20%
|
CAGR 10-Years
N/A
|
|
|
Y
|
YSP Southeast Asia Holding Bhd
KLSE:YSPSAH
|
Cash from Operating Activities
myr49.7m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
13%
|
|
|
K
|
Kotra Industries Bhd
KLSE:KOTRA
|
Cash from Operating Activities
myr67.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
13%
|
CAGR 10-Years
7%
|
|
Duopharma Biotech Bhd
Glance View
Duopharma Biotech Bhd.is an investment holding company, which engages in the manufacturing and distribution of pharmaceutical products. The company is headquartered in Klang, Selangor. The company went IPO on 2002-07-18. The Company, through its subsidiaries is engaged in manufacturing, distribution, importing and exporting of pharmaceutical products and medicines. The firm also engaged in research and development of pharmaceutical products. Its subsidiaries include Duopharma (M) Sendirian Berhad, Duopharma Manufacturing (Bangi) Sdn. Bhd., Duopharma Marketing Sdn. Bhd., Duopharma Consumer Healthcare Sdn. Bhd., Duopharma HAPI Sdn. Bhd., Duopharma Innovation Sdn. Bhd., Unique Pharmacy (Penang) Sdn. Bhd., Sentosa Pharmacy Sdn. Bhd., Duopharma Manufacturing (Glenmarie) Sdn. Bhd., Negeri Pharmacy Sdn. Bhd., Duopharma (Singapore) Pte. Ltd. and DB (Philippines), Inc.
See Also
What is Duopharma Biotech Bhd's Cash from Operating Activities?
Cash from Operating Activities
93.6m
MYR
Based on the financial report for Sep 30, 2024, Duopharma Biotech Bhd's Cash from Operating Activities amounts to 93.6m MYR.
What is Duopharma Biotech Bhd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
13%
Over the last year, the Cash from Operating Activities growth was 157%. The average annual Cash from Operating Activities growth rates for Duopharma Biotech Bhd have been 136% over the past three years , 7% over the past five years , and 13% over the past ten years .
You don't have any saved screeners yet